AbCellera Biologics Inc vs Apartment Investment and Management Co — how do they compare? AbCellera Biologics Inc trades at $9.29 (market cap $2.99B), while Apartment Investment and Management Co trades at $2.61 (market cap $376.16M). The key difference: AbCellera Biologics Inc is far larger — about 7.9× Apartment Investment and Management Co's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Apartment Investment and Management Co nearer its low. Which is the better fit depends on your goals.
| ABCL | AIV | |
|---|---|---|
Market Cap | $2.99B | $376.16M |
Sector | Health | Real Estate |
52-Week High | $9.76 | $7.93 |
52-Week Low | $2.78 | $2.59 |
Enterprise Value | $2.58B | $738.32M |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment
Read more on AIV →